Photoof Erman Akkus from X
May 11, 2024, 12:27
Erman Akkus on GLP1 Agonists in T2DM and Risk of Urological Cancers
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X:
“GLP1 Agonists in T2DM and Risk of Prostate Kidney and Bladder Cancers
Bladder cancer
HR 147 106204 p 002
compared to SGLT2 inhibitors
Kidney cancer
HR 145 113186 p 0003
compared to metformin
Prostate cancer
HR 132 107163 p 0010
compared to insulin
Although the treatment of diabetes is crucial these data may effect treatment choice in individual cases.”
Read further.
Source: Erman Akkus/X